SCHEMBL4787621

SCHEMBL4787621

COc1ccc(CNc2nc(OCCCCCC(=O)NO)nc3ccccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.55
HDAC1 Q13547 7/20 0.55
HDAC8 Q9BY41 6/20 0.55
HDAC6 Q9UBN7 6/20 0.55
HDAC2 Q92769 4/20 0.55
ERBB2 P04626 3/20 0.55
HDAC3 O15379 3/20 0.55
HDAC4 P56524 3/20 0.55
HDAC7 Q8WUI4 3/20 0.55
HDAC10 Q969S8 3/20 0.55
HDAC11 Q96DB2 3/20 0.55
HDAC9 Q9UKV0 3/20 0.55
HDAC5 Q9UQL6 3/20 0.55
KDR P35968 2/20 0.55
APP P05067 1/20 0.54
POLB P06746 2/20 0.51
NR2F2 P24468 1/20 0.51
SLC2A1 P11166 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4737141 1.00 EGFR (0.55) EGFRHDAC1HDAC8HDAC6HDAC2
SCHEMBL4737097 0.99 APP (0.55) EGFRHDAC1HDAC8HDAC6HDAC2
SCHEMBL4742773 0.85 SLC2A1 (0.57) HDAC1HDAC8HDAC6HDAC2HDAC3
SCHEMBL4739328 0.85 SLC2A1 (0.57) HDAC1HDAC8HDAC6HDAC2HDAC3
SCHEMBL4737772 0.85 SLC2A1 (0.57) HDAC1HDAC8HDAC6HDAC2HDAC3
SCHEMBL3960300 0.83 LMNA (0.53) EGFRHDAC1HDAC8HDAC6HDAC2
SCHEMBL3109840 0.82 APP (0.65) EGFRAPPPOLBNR2F2SLC2A1
SCHEMBL3118629 0.79 APP (0.68) EGFRAPPPOLBNR2F2SLC2A1
SCHEMBL4787633 0.79 HDAC1 (0.73) EGFRHDAC1HDAC8HDAC6HDAC2
SCHEMBL4737144 0.79 HDAC1 (0.73) EGFRHDAC1HDAC8HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033747-A9 MULTI-FUNCTIONAL SMALL MOLECULES AS ANTI-PROLIFERATIVE AGENTS CURIS INC (MA) 2008-07-24 WO disclosed